FOR PHARMACISTS · REFERENCE EDITION 8.0261 monographs · 32 SOPs · 18 forms
Sikaliascompounding.grSikalias Greek Formulary
Home / Microbiological quality and preservative effectiveness

SOP-019 / SOP v1.0

Microbiological quality and preservative effectiveness

Nonsterile forms and preservation studies in the exact final matrix.

Download individual SOP · PDF

Procedure

  1. Define route, population, formula, pH, preservation and packaging. Select applicable full compendial methods and limits with the analytical laboratory.
  2. Distinguish enumeration/specified-organism testing from preservative-effectiveness testing. Passing the former does not establish the latter.
  3. Verify method suitability in the matrix, organism recovery and preservative neutralisation/removal. Failed recovery is not reported as absence of microorganisms.
  4. Link challenge testing to complete preservative concentrations, container material and use conditions. A supplier report for another base requires documented applicability.
  5. For BUD extension assess chemical, physical and microbiological evidence together. Record sampling times, results and predefined criteria in F-013.
  6. Specification failure requires quarantine, investigation and review of shared materials/water/equipment. Do not repeat testing merely until a passing result appears.
Stop criterion

Invalid method or failed critical microbiological criterion: no release.

Related forms

F-005, F-006, F-013

Sources and references

  1. PIC/S — Guide to Good Practices for the Preparation of Medicinal Products in Healthcare EstablishmentsPE 010-4, 1 March 2014Chapters 1–9; Annex 2 (nonsterile liquids, creams, ointments)Professional quality-system framework; not automatic national legal adoption or certification2026-09-12
  2. Illinois IDFPR — Nonsterile Compounding Self-Inspection ReportPublic regulatory checklist, accessed 2026-09-12pp. 15–16; USP <795> sections 10.1–10.5Temperature conditions and requirements for supported extension; jurisdiction-specific guidance2026-09-12
  3. EMA — Guideline on Allergen Products: Production and Quality IssuesEMEA/CHMP/BWP/304831/2007, 2008Sections 2, 4.1.1, 4.2.4, 4.3, 4.4.3–4.4.5; pp. 4–13Industrial biological-allergen quality guidance; principles adapted explicitly, not a compounding authorisation or a food-OIT recipe2026-09-12